China Resources Double-Crane Pharmaceutical Co., Ltd.
-
Founded in:
1997-05-16 -
Country:
China -
Address:
No. 1, Lize East 2nd Road, Wangjing, Chaoyang District, Beijing -
Tax NO.:
91110000633796475U -
Registered Funds:
1,038,836,522 yuan -
Website:
-
Email:
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Ketotifen fumarate |
It has both histamine H1 receptor antagonism and the effect of inhibiting the release of allergic reaction mediators. It not only has a strong anti-allergic effect, but also has a longer duration of efficacy. It is more effective in preventing various bronchial asthma attacks and exogenous asthma than endogenous asthma.
More
It has both histamine H1 receptor antagonism and the effect of inhibiting the release of allergic reaction mediators. It not only has a strong anti-allergic effect, but also has a longer duration of efficacy. It is more effective in preventing various bronchial asthma attacks and exogenous asthma than endogenous asthma. |
1.38mg | 34580-14-8 | 13 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Ketotifen fumarate |
It has both histamine H1 receptor antagonism and the effect of inhibiting the release of allergic reaction mediators. It not only has a strong anti-allergic effect, but also has a longer duration of efficacy. It is more effective in preventing various bronchial asthma attacks and exogenous asthma than endogenous asthma.
More
It has both histamine H1 receptor antagonism and the effect of inhibiting the release of allergic reaction mediators. It not only has a strong anti-allergic effect, but also has a longer duration of efficacy. It is more effective in preventing various bronchial asthma attacks and exogenous asthma than endogenous asthma. |
1.38mg | 34580-14-8 | 13 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Ketotifen fumarate |
This product has both histamine H1 receptor antagonism and the effect of inhibiting the release of allergic reaction mediators. It not only has a strong anti-allergic effect, but also has a longer duration of efficacy. Therefore, it is more effective in preventing various bronchial asthma attacks and exogenous asthma than endogenous asthma.
More
This product has both histamine H1 receptor antagonism and the effect of inhibiting the release of allergic reaction mediators. It not only has a strong anti-allergic effect, but also has a longer duration of efficacy. Therefore, it is more effective in preventing various bronchial asthma attacks and exogenous asthma than endogenous asthma. |
1.38mg | 34580-14-8 | 13 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Ketotifen fumarate |
It has both histamine H1 receptor antagonism and the effect of inhibiting the release of allergic reaction mediators. It not only has a strong anti-allergic effect, but also has a longer duration of efficacy. Therefore, it is more effective in preventing various bronchial asthma attacks and exogenous asthma than endogenous asthma.
More
It has both histamine H1 receptor antagonism and the effect of inhibiting the release of allergic reaction mediators. It not only has a strong anti-allergic effect, but also has a longer duration of efficacy. Therefore, it is more effective in preventing various bronchial asthma attacks and exogenous asthma than endogenous asthma. |
1.38mg | 34580-14-8 | 13 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Atropine |
|
51-55-8 | 6 |